natgillin/translations-raw huggingface dataset:
Substances that may enhance the blood-glucose-lowering activity and increase susceptibility to hypoglycaemia include oral antidiabetic medicinal products, angiotensin converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors (MAOIs), pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics.
Med zdravili, ki lahko stopnjujejo učinek znižanja glukoze v krvi in zvečajo nagnjenost k hipoglikemiji, so peroralni antidiabetiki, zaviralci angiotenzinske konvertaze (ACE), dizopiramid, fibrati, fluoksetin, zaviralci monoaminooksidaze (MAO), pentoksifilin, propoksifen, salicilati in sulfonamidni antibiotiki.
Fertility Animal reproduction studies with insulin glulisine have not revealed any adverse effects on fertility.
Študije na živalih ne kažejo neposrednih škodljivih učinkov na plodnost.
When used with an insulin infusion pump, Apidra must not be mixed with other medicinal products.
Kadar se insulin Apidra uporablja v črpalki za infundiranje insulina, se ga ne sme mešati z nobenim drugim zdravilom.
Data indicated that insulin glulisine administered 2 minutes before the meal gives similar postprandial glycaemic control compared to regular human insulin given 30 minutes before the meal.
Podatki kažejo, da insulin glulisin, apliciran 2 minuti pred obrokom, povzroči podobno postprandialno urejenost glikemije kot navadni humani insulin, uporabljen 30 minut pred obrokom.
Patients administering Apidra by CSII must have an alternative insulin delivery system available in case of pump system failure (see section 4.4 and 4.8).
Bolniki, ki zdravilo Apidra uporabljajo v CSII, morajo vedno imeti na voljo še drug sistem za dajanje insulina za primer, da sistem s črpalko odpove (glejte poglavji 4.4 in 4.8).
Systemic allergic reactions are side effects reported uncommonly (may affect up to 1 in 100 people).
Občasno se lahko pojavijo sistemske alergijske reakcije (prizadanejo lahko največ 1 od 100 bolnikov).
When given 2 minutes prior to meal, insulin glulisine provided better postprandial control than regular human insulin given 2 minutes before the meal.
Insulin glulisin, uporabljen 2 minuti pred obrokom, je zagotovil boljšo postprandialno urejenost kot navadni humani insulin, uporabljen 2 minuti pred obrokom.
MedDRA
Odmerek
Each cartridge contains 3 ml solution (300 Units).
Vsak vložek vsebuje 3 ml raztopine (300 enot).
Before use always attach a new needle, and perform a safety test. Only use needles that are compatible for use with SoloStar (see “SoloStar Instructions for use”).
Uporabljajte le igle, primerne za uporabo s SoloStarjem (glejte "Navodila za ravnanje s SoloStarjem").
After removing the cap, the needle should be carefully attached straight onto the pen.
Po odstranitvi pokrovčka injekcijskega peresnika morate iglo natančno namestiti naravnost na injekcijski peresnik.
Insulin glulisine given 15 minutes (GLULISINE post) after start of a meal compared to regular human insulin given 2 minutes (REGULAR pre) before start of the meal (figure 1C).
Insulin glulisin, uporabljen 15 minut (GLULISIN - po) po začetku obroka, v primerjavi z navadnim humanim insulinom, uporabljenim 2 minuti (NAVADNI- pred) pred začetkom obroka (slika 1C).
Apidra in a pre-filled pen is only suitable for injecting just under the skin.
Zdravilo Apidra v napolnjenem injekcijskem peresniku je primerno samo za injiciranje tik pod kožo.
Apidra with alcohol
Zdravilo Apidra skupaj s hrano, pijačo in alkoholom
The pen in use must not be stored in a refrigerator.
Vložka, ki ga uporabljate, ne smete shranjevati v hladilniku.
Each ml of the solution contains 100 Units of insulin glulisine (equivalent to 3.49 mg).
Vsak mililiter raztopine vsebuje 100 enot insulina glulisin (kar ustreza 3,49 mg).
Then the injection button should be held down 10 seconds before withdrawing the needle.
Preden se igla potegne iz kože, je treba gumb za injiciranje držati pritisnjen 10 sekund.
• General disorders and administration site conditions Systemic hypersensitivity reactions may include urticaria, chest tightness, dyspnoea, allergic dermatitis and pruritus.
Sistemske preobčutljivostne reakcije lahko vključujejo urtikarijo, tiščanje v prsih, dispnejo, alergijski dermatitis in srbenje.
In a study with 18 male subjects with diabetes mellitus type 1, aged 21 to 50 years, insulin glulisine displays dose-proportionality for early, maximum and total exposure in the dose range 0.075 to 0.4 Units/kg.
V študiji z 18 osebami moškega spola z diabetesom mellitusom tipa 1, starimi od 21 do 50 let, je bila zgodnja, največja in skupna izpostavljenost insulinu glulisin v razponu odmerkov od 0,075 do 0,4 enot/kg sorazmerna z odmerkom.
Upon regaining consciousness, administration of oral carbohydrate is recommended for the patient in order to prevent relapse.
Ko se bolnik spet zave, je priporočljivo, da za preprečitev ponovitve peroralno dobi ogljikove hidrate.
Description of selected adverse reactions
Opis izbranih neželenih učinkov Presnovne in prehranske motnje
Apidra in cartridges is only suitable for injecting just under the skin using a reusable pen (see also section 3).
Zdravilo Apidra v vložku je primerno samo za injiciranje tik pod kožo z injekcijskim peresnikom za večkratno uporabo (glejte tudi poglavje 3).
Hepatic impairment The pharmacokinetic properties have not been investigated in patients with impaired liver function.
Okvara jeter Farmakokinetične lastnosti pri bolnikih z okvarjenim delovanjem jeter niso raziskane.
Before using SoloStar, the Instructions for use included in the Package leaflet must be read carefully.
Pred uporabo SoloStarja natančno preberite navodila za ravnanje z injekcijskim peresnikom v navodilu za uporabo.
Insulin glulisine administered 15 minutes after starting the meal gives similar glycaemic control as regular human insulin given 2 minutes before the meal (see figure 1).
Insulin glulisin, uporabljen 15 minut po začetku obroka, doseže podobno urejenost glikemije kot navadni humani insulin, uporabljen 2 minuti pred obrokom (slika 1).
Step 2 Attach the needle
Korak 2 Namestitev igle
Substances that may reduce the blood-glucose-lowering activity include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, phenothiazine derivatives, somatropin, sympathomimetic medicinal products (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, oestrogens, progestins (e.g. in oral contraceptives), protease inhibitors and atypical antipsychotic medicinal products (e.g. olanzapine and clozapine).
Med zdravili, ki lahko zmanjšajo učinek znižanja glukoze v krvi, so kortikosteroidi, danazol, diazoksid, diuretiki, glukagon, izoniazid, derivati fenotiazina, somatropin, simpatikomimetiki (npr. adrenalin, salbutamol, terbutalin), ščitnični hormoni, estrogeni, progestini (npr. v peroralnih kontraceptivih), zaviralci proteaz in atipični antipsihotiki (npr. olanzapin in klozapin).
- If you have injected too much Apidra, your blood sugar level may become too low (hypoglycaemia).
Če ste injicirali preveč zdravila Apidra, se vam lahko koncentracija krvnega sladkorja preveč zniža (hipoglikemija).
Before first use, the pen must be stored at room temperature for 1 to 2 hours.
Pred prvo uporabo mora biti injekcijski peresnik 1 do 2 uri na sobni temperaturi.
Insulin label must always be checked before each injection to avoid medication errors between insulin glulisine and other insulins (see section 4.4).
Da bi se izognili napakam zdravljenja zaradi zamenjave med insulinom glulisin in drugimi insulini, je potrebno nalepko insulina vedno preveriti pred vsakim injiciranjem (glejte poglavje 4.4).
After first use: The product may be stored for a maximum of 4 weeks below 25°C.
Po prvi uporabi: zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 25°C.
No increase in the basal insulin dose was needed with insulin glulisine, in contrast to insulin lispro.
V nasprotju z insulinom lispro ob insulinu glulisin ni bilo treba zvečati odmerka bazalnega insulina.
Local hypersensitivity reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin.
Med zdravljenjem z insulinom se lahko pojavijo lokalne preobčutljivostne reakcije (pordelost, oteklost in srbenje na mestu injiciranja).
In-use pens For storage conditions after first opening of the medicinal product, see section 6.3.
Uporabljeni injekcijski peresniki Za pogoje shranjevanja po prvem odprtju zdravila glejte poglavje 6.3.
Change the infusion set and reservoir at least every 48 hours using aseptic technique.
Infuzijski komplet in rezervoar morate zamenjati na 48 ur; menjavo morate opraviti aseptično.
Talk with your doctor, pharmacist or nurse about proper injection technique before using SoloStar.
Preden začnete uporabljati SoloStar, se pogovorite s svojim zdravnikom, s farmacevtom ali z medicinsko sestro o pravilni tehniki injiciranja.
B. Take off the pen cap. C. Check the appearance of your insulin.
C. Preverite videz insulina.
Apidra in cartridges is only suitable for injecting just under the skin using a reusable pen.
Zdravilo Apidra v vložku je primerno samo za injiciranje tik pod kožo z injekcijskim peresnikom za večkratno uporabo.
When compared with soluble human insulin, if hypoglycaemia occurs after an injection with rapid acting analogues, it may occur earlier.
Po injiciranju hitrodelujočih analogov se lahko hipoglikemija, če do nje pride, pojavi bolj zgodaj kot po topnem humanem insulinu.
2 vials of 10ml.
2 viali z 10 ml.
Hypoglycaemia is a very commonly reported side effect (may affect more than 1 in 10 people).
Hipoglikemija je zelo pogost neželeni učinek (pojavi se pri 1 od 10 bolnikov).
The average total GIR AUC between 0-1 hour was 102 ± 75 mg/kg and 158 ± 100 mg/kg with 0.2 and 0.4 Units/kg insulin glulisine, respectively, and was 83.1 ± 72.8 mg/kg and 112.3 ± 70.8 mg/kg with 0.2 and 0.4 Units/kg insulin lispro, respectively.
Pri odmerku 0,2 enot/kg insulina lispro je bila 83,1 ± 72,8 mg/kg, pri odmerku 0,4 enot/kg insulina lispro pa 112,3 ± 70,8 mg/kg.
- The active substance is insulin glulisine.
- Zdravilna učinkovina je insulin glulisin.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Apidra SoloStar 100 Units/ml solution for injection Insulin glulisine
IME ZDRAVILA IN POT(I) UPORABE Apidra SoloStar 100 enot/ml raztopina za injiciranje insulin glulisin
Apidra 100 Units/ml solution for injection in a cartridge EU/1/04/285/005-012
Apidra 100 enot/ml raztopina za injiciranje v vložku EU/1/04/285/005-012
After dilution for intravenous use, the solution should be inspected visually for particulate matter prior to administration.
Po razredčenju za intravensko uporabo je treba raztopino pregledati in se prepričati, da ne vsebuje delcev.
To prevent any kind of contamination, the use of the pre-filled pen should remain strictly for a single patient use.
Da preprečimo kakršnokoli onesnaženje, sme napolnjeni injekcijski peresnik uporabljati strogo en sam bolnik.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom ali s farmacevtom.
Apidra 100 Units/ml solution for injection in a vial Each vial contains 10 ml of solution for injection, equivalent to 1000 Units.
Apidra 100 enot/ml raztopina za injiciranje v viali Vsaka viala vsebuje 10 ml raztopine za injiciranje, kar ustreza 1.000 enotam.
Injection button
Ravnanje z injekcijskim peresnikom
The injection button should be pressed in completely.
Gumb za injiciranje je treba pritisniti do konca.
Apidra SoloStar solution for injection in a pre-filled pen.
Apidra SoloStar raztopina za injiciranje v napolnjenem injekcijskem peresniku.
Insulin glulisine takes effect about twice as fast as regular human insulin and completes the glucose lowering effect about 2 hours earlier than regular human insulin.
Insulin glulisin doseže učinek približno dvakrat hitreje kot navadni humani insulin.
This leaflet was last revised in
Navodilo je bilo odobreno v
Do not use this medicine after the expiry date, which is stated on the carton and on the label of the vial after “EXP”.
Zdravila Apidra ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki viale poleg oznake“EXP” .
It must only be used if the solution is clear and colourless, not when cloudy or with visible particles.
Uporabiti se jo sme le, če je raztopina bistra in brezbarvna, ne pa, če je motna ali vsebuje vidne delce.
Packs of 1, 3, 4, 5, 6, 8, 9 and 10 pens are available.
Na voljo so pakiranja z 1, 3, 4, 5, 6, 8, 9 in 10 vložki.
8 pens of 3 ml.
8 vložkov s 3 ml.
EU/1/04/285/001 1 vial of 10ml EU/1/04/285/002 2 vials of 10ml.
EU/1/04/285/001 1 viala z 10 ml. EU/1/04/285/002 2 viali z 10 ml. EU/1/04/285/003 4 viale z 10 ml. EU/1/04/285/004 5 vial z 10 ml.
Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen 3 ml solution in a cartridge (colourless glass) with a plunger (elastomeric bromobutyl rubber) and a flanged cap (aluminium) with a stopper (elastomeric bromobutyl rubber).
Apidra SoloStar 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku 3 ml raztopine v vložku (iz brezbarvnega stekla) z batom (iz elastomerne bromobutilne gume) in s prirobljeno zaporko (iz aluminija) z zamaškom (iz elastomerne bromobutilne gume).
After its first use, the product may be stored for a maximum of 4 weeks below 25°C.
Po prvi uporabi lahko zdravilo shranjujete največ 4 tedne pri temperaturi do 25 °C.
4 vials of 10ml.
4 viale z 10 ml.
How to handle an infusion pump system
Ravnanje s sistemom z insulinsko črpalko
When administered as a subcutaneous injection, Apidra must not be mixed with other medicinal products except NPH human insulin.
Če se zdravilo Apidra uporablja v subkutani injekciji, se ne sme mešati z ostalimi zdravili razen z NPH (nevtralni protamin hagedorn) insulinom.
Apidra 100 Units/ml solution for injection in a vial is a clear, colourless, aqueous solution with no particles visible.
Apidra 100 enot/ml, raztopina za injiciranje v viali, je bistra, brezbarvna, vodna raztopina brez vidnih delcev.
Marketing Authorisation Holder: Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main Germany
Imetnik dovoljenja za promet: Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main Nemčija
Each cartridge contains 3 ml of solution for injection, equivalent to 300 Units.
Vsak vložek vsebuje 3 ml raztopine za injiciranje, kar ustreza 300 enotam.
Do not use this medicine after the expiry date, which is stated on the carton and on the label of the pen after “EXP”.
Zdravila Apidra ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki vložka poleg oznake“EXP”.
The product may be stored for a maximum of 4 weeks below 25°C.
Zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 25 °C.
The product may be stored for a maximum of 4 weeks below 25°C away from direct heat or direct light.
Zdravilo lahko shranjujete največ 4 tedne pri temperaturi do 25°C zaščiteno pred neposredno toploto ali svetlobo.
Sodium chloride Trometamol
Metakrezol, natrijev klorid, trometamol, polisorbat 20,
In a study with 18 male subjects with diabetes mellitus type 1 aged 21 to 50 years, insulin glulisine displayed dose-proportional glucose lowering effect in the therapeutic relevant dose range 0.075 to 0.15 Units/kg, and less than proportional increase in glucose lowering effect with 0.3 Units/kg or higher, like human insulin.
V študiji z 18 osebami moškega spola z diabetesom mellitusom tipa 1, starimi od 21 do 50 let, je bil učinek insulina glulisin na znižanje glukoze v krvi v razponu terapevtsko pomembnih odmerkov od 0,075 do 0,15 enot/kg sorazmeren z odmerkom.
5 vials of 10ml.
5 vial z 10 ml.
Please check section 6.4 of this SPC for instructions on how to store SoloStar.
Za navodila o shranjevanju SoloStarja glejte poglavje 6.4 tega navodila.
The effect will be slightly quicker if the insulin is injected into your abdomen.
Če insulin injicirate v trebuh, bo učinek nekoliko hitrejši.
Apidra 100 Units/ml solution for injection in a cartridge 3 ml solution in a cartridge (type I colourless glass) with a plunger (elastomeric bromobutyl rubber) and a flanged cap (aluminium) with a stopper (elastomeric bromobutyl rubber).
Apidra 100 enot/ml raztopina za injiciranje v vložku 3 ml raztopine v vložku (iz brezbarvnega stekla tipa 1) z batom (iz elastomerne bromobutilne gume) in s prirobljeno zaporko (iz aluminija) z zamaškom (iz elastomerne bromobutilne gume).
Measure your blood sugar level regularly to make sure you get the benefit of the insulin infusion and to make sure that the pump is working properly.
Da vam bo infundiranje insulina koristilo in da boste zagotovili pravilno delovanje črpalke, si morate redno meriti krvni sladkor.
When used with a subcutaneous insulin infusion pump, Apidra must not be mixed with diluents or any other insulin.
Če je zdravilo Apidra uporabljeno v črpalki za subkutano infundiranje, se ga ne sme mešati z redčili in tudi ne s kakšnim drugim insulinom.
Pre-filled pens in use (or carried as a spare) may be stored for a maximum of 4 weeks below 25°C and away from direct heat or direct light.
Injekcijske peresnike, ki jih uporabljate ali jih imate pri sebi za rezervo, lahko shranjujete največ 4 tedne pri temperaturi do 25°C in zaščitene pred neposredno toploto ali svetlobo.
What Apidra contains
Kaj vsebuje zdravilo Apidra
Before insertion of the cartridge into the reusable pen, the cartridge must be stored at room temperature for 1 to 2 hours.
Pred vstavitvijo v injekcijski peresnik za večkratno uporabo mora biti vložek od 1 do 2 uri na sobni temperaturi.
It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency.
Uporabiti se ga sme le, če je raztopina bistra, brezbarvna, vodi podobne konsistence in v njej ni vidnih trdnih delcev.
Packs of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges are available.
Na voljo so pakiranja z 1, 3, 4, 5, 6, 8, 9 in 10 injekcijskimi peresniki.
You must always check the insulin label before each injection to avoid mix-ups between Apidra and other insulins.
Da bi se izognili zamenjavi med zdravilom Apidra in drugimi insulini, vedno pred vsakim injiciranjem preverite nalepko insulina.
STATEMENT OF ACTIVE SUBSTANCE(S) Each ml contains 100 Units insulin glulisine (equivalent to 3.49 mg).
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Vsak ml vsebuje 100 enot insulina glulisin (kar ustreza 3,49 mg).
Lipodystrophy may occur at the injection site as a consequence of failure to rotate injection sites within an area.
Lipodistrofija na mestu injiciranja se lahko pojavi, če bolnik mest injiciranja na posameznem predelu ne menja krožno.
- The other ingredients are: metacresol (see section 2 under “Apidra contains metacresol”), sodium chloride (see section 2 under “Important information about some of the ingredients of Apidra”), trometamol, polysorbate 20, concentrated hydrochloric acid, sodium hydroxide, water for injections.
- Pomožne snovi so: metakrezol (glejte poglavje 2 Apidra vsebuje metakrezol), natrijev klorid, (glejte poglavje 2 Pomembne informacije o nekaterih sestavinah zdravila Apidra) trometamol, polisorbat 20, koncentrirana klorovodikova kislina, natrijev hidroksid, voda za injekcije.
Once in use, the vial may be stored for a maximum of 4 weeks in the outer carton below 25°C away from direct heat or direct light.
Ko vialo začnete uporabljati, jo lahko shranjujete največ 4 tedne pri temperaturi do 25°C zaščiteno pred neposredno toploto ali svetlobo v zunanji ovojnini.
To prevent any kind of contamination, the re-usable pen should be used by a single patient only.
Da preprečimo kakršnokoli onesnaženje, sme injekcijski peresnik za večkratno uporabo uporabljati samo en bolnik.
EU/1/04/285/011 9 cartridges of 3ml.
EU/1/04/285/011 9 vložkov s 3ml.
5 pens of 3 ml.
5 vložkov s 3 ml.
It must only be used if the solution is clear, colourless, with no solid particles visible.
Uporabiti se ga sme le, če je raztopina bistra, brezbarvna in v njej ni vidnih trdnih delcev.
Instruction for intravenous administration
Navodilo za intravensko uporabo
Packs of 1, 3, 4, 5, 6, 8, 9 and 10 pre-filled pens are available.
Na voljo so pakiranja z 1, 3, 4, 5, 6, 8, 9 in 10 napolnjenimi injekcijskimi peresniki.
Medicines that may cause your blood sugar level to fall (hypoglycaemia) include: - all other medicines to treat diabetes, - angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure), - disopyramide (used to treat certain heart conditions), - fluoxetine (used to treat depression), - fibrates (used to lower high levels of blood lipids), - monoamine oxidase (MAO) inhibitors (used to treat depression), - pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), - sulphonamide antibiotics.
Med zdravili, ki lahko povzročijo znižanje koncentracije krvnega sladkorja (hipoglikemija) so: vsa druga zdravila za zdravljenje sladkorne bolezni, zaviralci angiotenzinske konvertaze (ACE - angiotensin converting enzyme) (uporabljajo se za zdravljenje določenih bolezenskih stanj srca ali visokega krvnega tlaka), dizopiramid (uporablja se za zdravljenje določenih bolezenskih stanj srca), fluoksetin (uporablja se za zdravljenje depresije), fibrati (uporabljajo se za znižanje visokih koncentracij krvnih lipidov), zaviralci monoaminooksidaze (MAO) (uporabljajo se za zdravljenje depresije), pentoksifilin, propoksifen, salicilati (na primer acetilsalicilna kislina, uporabljajo se za lajšanje bolečine in znižanje zvišane telesne temperature), sulfonamidni antibiotiki.
Changing the injection site with each injection may help to prevent such skin changes.
Takšne kožne spremembe lahko preprečite z menjavanjem mesta injiciranja.
Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse.
Če opazite, da se urejenost vašega krvnega sladkorja nepričakovano poslabša, vedno uporabite nov injekcijski peresnik.
How to store Apidra
Shranjevanje zdravila Apidra
Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Each pen contains 3 ml of solution for injection, equivalent to 300 Units.
Apidra SoloStar 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku Vsak injekcijski peresnik vsebuje 3 ml raztopine za injiciranje, kar ustreza 300 enotam.
However, insulin requirements may be reduced in the presence of renal impairment.
Lahko pa se pri okvari ledvic zmanjša potreba po insulinu.
Apidra 100 Units/ml solution for injection in a vial Subcutaneous use
Apidra 100 enot/ml raztopina za injiciranje v viali Subkutana uporaba
Hypoglycaemia is also more likely to occur if: - you have just begun insulin treatment or changed to another insulin preparation, - your blood sugar levels are almost normal or are unstable,
Hipoglikemija je verjetnejša tudi, če: - ste zdravljenje z insulinom pravkar začeli ali ste prešli na drug pripravek insulina, - je koncentracija vašega krvnega sladkorja skoraj normalna ali ni stabilna, - zamenjate predel kože, kamor injicirate insulin (na primer s stegna na nadlaket), - imate hudo bolezen ledvic ali jeter ali kakšno drugo bolezen, npr. nezadostno delovanje ščitnice.
For information on the treatment of hyperglycaemia, see box at the end of this leaflet.
Informacije o zdravljenju hiperglikemije najdete v okvirju na koncu tega navodila za uporabo.
Apidra 100 Units/ml solution for injection in a cartridge Each cartridge contains 3 ml of solution for injection, equivalent to 300 Units.
Apidra 100 enot/ml raztopina za injiciranje v vložku Vsak vložek vsebuje 3 ml raztopine za injiciranje, kar ustreza 300 enotam.
Then the injection button should be pressed in completely.
Potem morate gumb za injiciranje pritisniti do konca.
Apidra 100 Units/ml solution for injection in a vial Shelf life after first use of the vial
Apidra 100 enot/ml raztopina za injiciranje v viali Rok uporabnosti po prvi uporabi viale:
Talk to your doctor, pharmacist or nurse before using Apidra.
Posvetujte se z zdravnikom ali s farmacevtom, preden vzamete katerokoli zdravilo.
10 pens of 3 ml.
10 vložkov s 3 ml.